In the case of Kellesis v. Paramed dated October 11, 2023, involved a previous decision made by a judge regarding a class action lawsuit in London, Ontario, involving the plaintiff Sara Kellesis and the defendant, Paramed. The lawsuit had stemmed from Paramed's failure over a 10-year period to adhere to public health standards for sterilizing medical instruments at its wound care clinics. This lapse in infection control had posed a potential risk of serious communicable diseases to its clients, such as hepatitis B, hepatitis C, and HIV. The case had been divided into two subclasses: the "Infected Persons Class" and the "Uninfected Persons Class." The compensation plan had offered individual payouts ranging from $10,000 to $25,000 depending on the specific illness (HIV, hepatitis B, or hepatitis C) contracted by the claimant. Prospective Settlement Class Members had only needed to submit a claim form with supporting documentation within three months of court approval. No objections had been raised during the settlement approval process, and the judge had found the settlement to be fair and in the best interests of the class. Class Counsel's fees had been deemed reasonable, representing a 30% contingency fee, and the judge had commended their efforts throughout the proceeding, acknowledging the risks they had taken. The settlement and class counsel fees had been approved, providing compensation to the affected individuals while avoiding prolonged litigation and uncertainties related to causation. No specific amount had been provided in the case regarding the financial award.